BioCryst Pharmaceuticals Inc: Premium Company Profile

Questions: Discounts, Updates etc.

Price: $495.00

Publication Date: 2007-12-17

Order Online Now

People that purchased this report also purchased:

Contact LeadDiscovery

  • If you have questions about this report
  • To find out if you qualify for a discount
  • Want a more up to date version
  • Can't find a report that meets your needs
Search all reports

Keywords:

Boolean terms AND, OR, NOT can be used. Phrases should be entered within quotes. For wildcards use an *

BioCryst Pharmaceuticals is a leading biopharmaceutical company in the use of crystallography and structure-based drug design for the development of novel therapeutics to treat cancer, cardiovascular diseases, autoimmune diseases, and viral infections.


Scope

  • Contains corporate strategy, value chain presence and SWOT Analysis
  • Provides detailed business description, segment analysis, 5-year financial trends, key products and key competitors
  • Includes information on suppliers/ partners, shareholding structure and key employees with biographies


    • Report Highlights
    BioCryst develops small-molecule inhibitors of enzymes that treat cancer, autoimmune diseases, and viral infections. Its lead product candidate, Forodesine (Fodosine), is a transition-state analog inhibitor of the target enzyme purine nucleoside phosphorylase (PNP).

    The company's total revenues recorded an absolute growth of +$6 million during 2002-2006. It did not receive revenues in 2002, and started recording revenues 2003 onwards. Revenues of BioCryst increased from $1 million in 2003 to $6 million in 2006.

    Total revenues of the company are expected to increase at a CAGR of 74%, from $6 million in 2006 to $58 million in 2010. This represents an absolute growth of +$51 million between 2006 and 2010.


    Reasons to Purchase

  • Access all the important information and analysis on the company in a single report
  • Understand company's strengths, weaknesses, opportunities and threats along with business strategy and value chain
  • Gain access to company's adjusted five year financial data along with key ratios and market capitalization

    • Table of Contents

    Other users found this report page using the following search terms: biocryst yarlagadda bcx4208 pharmaceuticals email babu spencer structure publications seidenberg

    If you can't find a report that meets your needs contact LeadDiscovery. We are one of the few report providers with extensive drug development experience and we frequently use this knowledge to help clients source the most appropriate reports or produce reports for them from scratch.


    Refund and Cancellation Policy: The descriptions of the products and services sold on LeadDiscovery.co.uk are as complete and accurate as possible, and customers are encouraged to read all available information about a product before placing an order. Due to the nature of the information being sold, orders for reports cannot be canceled.